Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)

Aim. In a clinical and epidemiological study PERSPECTIVE, to investigate the secondary prevention implementation among stable angina patients in real-world clinical practice, and to evaluate compliance to Russian and international clinical guidelines on stable angina management. Material and methods...

Full description

Saved in:
Bibliographic Details
Main Authors: M. G. Bubnova, D. M. Aronov, R. G. Oganov, O. G. Rudomanov, A. S. Putylina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2010-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/2144
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342242900148224
author M. G. Bubnova
D. M. Aronov
R. G. Oganov
O. G. Rudomanov
A. S. Putylina
author_facet M. G. Bubnova
D. M. Aronov
R. G. Oganov
O. G. Rudomanov
A. S. Putylina
author_sort M. G. Bubnova
collection DOAJ
description Aim. In a clinical and epidemiological study PERSPECTIVE, to investigate the secondary prevention implementation among stable angina patients in real-world clinical practice, and to evaluate compliance to Russian and international clinical guidelines on stable angina management. Material and methods. The study involved general practitioners and cardiologists (n=277). In the first part of the PERSPECTIVE Study, the data from out-patient medical histories (2768 patients with verified diagnosis of stable angina, SA) were analysed. Results. In SA patients, the prevalence of coronary risk factors (RFs) was high. The mean levels of blood pressure, blood lipids and lipoproteins, body mass index, and heart rate were substantially higher than the recommended target levels. At the same time, some positive changes in the clinical course of SA were observed, such as reduced incidence of angina attacks, decreased number of administered nitroglycerine tablets, and increased prevalence of Functional Class I-II SA. The qualitative changes in prescribed medications, including antianginal, anti-aggregant, and lipid-lowering agents, were also observed. Conclusion. The results obtained point to the need for further improvement of SA management in real-world clinical practice and for optimization of pharmaceutical therapy, in accordance with modern Russian and international clinical guidelines.
format Article
id doaj-art-7bd34631230e48c488d9cdeeb3213cf0
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2010-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-7bd34631230e48c488d9cdeeb3213cf02025-08-20T03:43:27Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252010-12-019647561853Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)M. G. Bubnova0D. M. Aronov1R. G. Oganov2O. G. Rudomanov3A. S. Putylina4State Research Centre for Preventive Medicine. MoscowState Research Centre for Preventive Medicine. MoscowState Research Centre for Preventive Medicine. MoscowServier LaboratoriesServier LaboratoriesAim. In a clinical and epidemiological study PERSPECTIVE, to investigate the secondary prevention implementation among stable angina patients in real-world clinical practice, and to evaluate compliance to Russian and international clinical guidelines on stable angina management. Material and methods. The study involved general practitioners and cardiologists (n=277). In the first part of the PERSPECTIVE Study, the data from out-patient medical histories (2768 patients with verified diagnosis of stable angina, SA) were analysed. Results. In SA patients, the prevalence of coronary risk factors (RFs) was high. The mean levels of blood pressure, blood lipids and lipoproteins, body mass index, and heart rate were substantially higher than the recommended target levels. At the same time, some positive changes in the clinical course of SA were observed, such as reduced incidence of angina attacks, decreased number of administered nitroglycerine tablets, and increased prevalence of Functional Class I-II SA. The qualitative changes in prescribed medications, including antianginal, anti-aggregant, and lipid-lowering agents, were also observed. Conclusion. The results obtained point to the need for further improvement of SA management in real-world clinical practice and for optimization of pharmaceutical therapy, in accordance with modern Russian and international clinical guidelines.https://cardiovascular.elpub.ru/jour/article/view/2144stable anginasecondary preventionrisk factorstherapy
spellingShingle M. G. Bubnova
D. M. Aronov
R. G. Oganov
O. G. Rudomanov
A. S. Putylina
Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
Кардиоваскулярная терапия и профилактика
stable angina
secondary prevention
risk factors
therapy
title Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
title_full Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
title_fullStr Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
title_full_unstemmed Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
title_short Clinical characteristics of stable angina patients and their treatment strategies in real-world clinical practice. A Russian PERSPECTIVE Study (Part I)
title_sort clinical characteristics of stable angina patients and their treatment strategies in real world clinical practice a russian perspective study part i
topic stable angina
secondary prevention
risk factors
therapy
url https://cardiovascular.elpub.ru/jour/article/view/2144
work_keys_str_mv AT mgbubnova clinicalcharacteristicsofstableanginapatientsandtheirtreatmentstrategiesinrealworldclinicalpracticearussianperspectivestudyparti
AT dmaronov clinicalcharacteristicsofstableanginapatientsandtheirtreatmentstrategiesinrealworldclinicalpracticearussianperspectivestudyparti
AT rgoganov clinicalcharacteristicsofstableanginapatientsandtheirtreatmentstrategiesinrealworldclinicalpracticearussianperspectivestudyparti
AT ogrudomanov clinicalcharacteristicsofstableanginapatientsandtheirtreatmentstrategiesinrealworldclinicalpracticearussianperspectivestudyparti
AT asputylina clinicalcharacteristicsofstableanginapatientsandtheirtreatmentstrategiesinrealworldclinicalpracticearussianperspectivestudyparti